Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study

Loomba R, Lawitz EJ, Frias JP, Ortiz-Lasanta G, Johansson L, Boggess Franey B, Morrow L, Rosenstock M, Hartsfield CL, Chen C-Y, Tseng L, Charlton RW, Mansbach H, Margalit M


Lancet Gastroenterol. Hepatol. 2022 Dec 12. doi: 10.1016/ S2468-1253(22)00347-8. Online ahead of print.

View abstract Share on Linkedin Share on Twitter